Filter by:


Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Devinsky, O.; Cross, J. H.; Laux, L.; Marsh, E.; Miller, I.; Nabbout, R.; Scheffer, I. E.; Thiele, E. A.; Wright, S. N Engl J Med. 2017 May 26; 376(21):2011-2020

Screening of conventional anticonvulsants in a genetic mouse model of epilepsy

Hawkins, N. A.; Anderson, L. L.; Gertler, T. S.; Laux, L.; George, A. L., Jr.; Kearney, J. A. Ann Clin Transl Neurol. 2017 May 12; 4(5):326-339

Seizure Outcomes in Children Following Electrocorticography-Guided Single-Stage Surgical Resection

Bansal, S.; Kim, A. J.; Berg, A. T.; Koh, S.; Laux, L. C.; Nangia, S.; Millichap, J. J.; Shaw, A.; Fisher, B.; Dezort, C.; DiPatri, A. J., Jr.; Alden, T. D.; Nordli, D. R., Jr. Pediatr Neurol. 2017 May 10; 71:35-42

Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases

Gofshteyn, J. S.; Wilfong, A.; Devinsky, O.; Bluvstein, J.; Charuta, J.; Ciliberto, M. A.; Laux, L.; Marsh, E. D. J Child Neurol. 2016 Sep 23; 32(1):35-40

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

Devinsky, O.; Marsh, E.; Friedman, D.; Thiele, E.; Laux, L.; Sullivan, J.; Miller, I.; Flamini, R.; Wilfong, A.; Filloux, F.; Wong, M.; Tilton, N.; Bruno, P.; Bluvstein, J.; Hedlund, J.; Kamens, R.; Maclean, J.; Nangia, S.; Singhal, N. S.; Wilson, C. A.; Patel, A.; Cilio, M. R. Lancet Neurol. 2016 Jan 3; 15(3):270-8